Breast cancer+2
RecruitingLong-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study
Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study
- Disease:Breast cancerOvarian cancer+1
- Substances:Niraparib Tosilate Monohydrate
Austria- Participants:18–64 years · 65+ years
- Substances:Niraparib Tosilate Monohydrate
- Sponsor:Glaxosmithkline Research & Development Limited












